about
P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma developmentMathematical models of cancer metabolismSerine and glycine metabolism in cancerRedox control of glutamine utilization in cancerTwo-way communication between the metabolic and cell cycle machineries: the molecular basisMitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availabilityNeu-Laxova syndrome is a heterogeneous metabolic disorder caused by defects in enzymes of the L-serine biosynthesis pathwayp63 transcriptionally regulates the expression of matrix metallopeptidase 13.One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy.Regulation of the pentose phosphate pathway in cancerMetabolic effect of TAp63α: enhanced glycolysis and pentose phosphate pathway, resulting in increased antioxidant defenseTAp73 promotes anti-senescence-anabolism not proliferation.Bioinformatics analysis of the serine and glycine pathway in cancer cellsTAp73 promotes anabolismcMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions.Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.TAp73 transcriptionally represses BNIP3 expression.Three-minute method for amino acid analysis by UHPLC and high-resolution quadrupole orbitrap mass spectrometry.p73 regulates basal and starvation-induced liver metabolism in vivo.Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancerMetabolic pathways regulated by TAp73 in response to oxidative stressHow the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors.A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.NF-Y activates genes of metabolic pathways altered in cancer cells.Phosphoglycerate dehydrogenase: potential therapeutic target and putative metabolic oncogene.Uncovering metabolism in rhabdomyosarcoma.Glutamine at focus: versatile roles in cancer.TAp73 upregulates IL-1β in cancer cells: Potential biomarker in lung and breast cancer?ΔNp63 targets cytoglobin to inhibit oxidative stress-induced apoptosis in keratinocytes and lung cancer.High level PHGDH expression in breast is predominantly associated with keratin 5-positive cell lineage independently of malignancy.Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype.Large scale integration of drug-target information reveals poly-pharmacological drug action mechanisms in tumor cell line growth inhibition assays.The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.Non-oncogenic roles of TAp73: from multiciliogenesis to metabolism.Systematic analyses of glutamine and glutamate metabolisms across different cancer types.TAp73 is a marker of glutamine addiction in medulloblastoma.p73 Regulates Primary Cortical Neuron Metabolism: a Global Metabolic Profile.The hypoxic tumour microenvironment.Integrin-β4 is a novel transcriptional target of TAp73.Chloroplastic Serine Hydroxymethyltransferase From Medicago truncatula: A Structural Characterization.
P2860
Q26771603-A6F5DA92-6214-487F-9246-D4A4B2A2F30EQ26772067-CD727074-2C36-4ECF-B75D-5A2DD1BA083FQ26863700-110DF5CF-D452-404B-8986-75AF36F60D7EQ27005615-70D830E9-B8F2-4549-914B-F8C9024B32D2Q27013594-DA8195E9-BAC8-4BFD-88E5-BC6F15C09860Q28242891-7CEF60C9-3947-4EDA-9B35-9141F07F3AFEQ28246648-57581E0C-48ED-4458-9188-56D4D7304258Q33576855-DD9C7430-1361-492B-A183-3AA4E2F45E89Q33618935-1C89B602-A5F9-4458-8A34-6AC4B1150E62Q33955739-BC7820D0-75C4-417E-BA46-B081EFD69CE7Q34365852-91D1B0AC-3EF6-421C-98E1-49C72FE0DFC1Q34774270-CF3E6875-2B9B-40E0-A3BF-754E601403E2Q34956789-FB3444C5-1630-4BAC-B6AD-4790C650ADBDQ35149652-EABCDB03-A37F-48C4-B539-DDF6383B5919Q35291859-2123E07B-9CC1-4C52-A93A-736B1490EB2BQ35955331-0C59287A-0906-49E6-A15A-32C2D3E4C746Q36182254-1A38D7AC-65A3-4E42-B7F6-EB5C96E07BF9Q36218137-73EEA017-F430-458A-B64C-7658BC1CF1F8Q36545105-B4CDDFF7-268D-44BD-921A-AA358D53F76FQ37249091-B87681ED-C988-430D-A469-258408723CA1Q37327366-E6B18E4B-964F-44BB-B0BD-0610C3EB38BEQ38184518-0FE5A4E8-7501-4A8E-90B3-DA5FD7710D4FQ38266299-FF1900AE-30DE-49B4-91C1-746F2EF647A9Q38294889-789522E7-9B41-4E36-9D29-A70FBE866DB3Q38312559-C4E1EE29-A9A7-4458-81EA-74F0B29B8427Q38553827-287543DA-E915-4111-BD9A-16CD7789BE2FQ38678184-E89FBF2C-1FDE-44DE-AF68-CCFD2EC99DFAQ38716015-D3B32A8D-DF9B-43DE-ACD3-B3BB5DA7E969Q38861412-CC6F1EDA-5185-4E16-A6F6-04B58E2EA93EQ38869310-E8DE868C-9825-4795-A174-C3B1ACE273F1Q38874166-A84D86CE-5618-473D-A178-EBF56B4E4DA6Q38915003-F40A4500-575E-4F04-8551-9AEC28FC0D42Q42016261-338DEFC2-FD27-454B-A1F4-2FC735AE6DC5Q46273393-416040E5-54BE-46BB-A2EC-AF2FF969A1D2Q47155640-E1AFD2E7-3B98-4EA8-8265-CBEC7E306346Q47161374-238119BB-C57F-4D43-97BA-D5B1055CCC15Q47899475-99AB5EC3-E20B-4970-922E-0E0FA9A7A710Q48181172-8575639B-3CB3-41DA-8C42-483EA8E7E53CQ49892600-F857348A-1521-4668-BD49-8F28E15C8811Q54961325-634145DE-6324-4C98-A227-AEE52018D662
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
p73 regulates serine biosynthesis in cancer.
@en
p73 regulates serine biosynthesis in cancer.
@nl
type
label
p73 regulates serine biosynthesis in cancer.
@en
p73 regulates serine biosynthesis in cancer.
@nl
prefLabel
p73 regulates serine biosynthesis in cancer.
@en
p73 regulates serine biosynthesis in cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
p73 regulates serine biosynthesis in cancer
@en
P2093
A J Levine
A V Antonov
E K Markert
P2860
P2888
P304
P356
10.1038/ONC.2013.456
P407
P577
2013-11-04T00:00:00Z